| 1 |
[GO] |
2023―Jul―19 |
COVID-19-Associated Pulmonary Embolism: Facts and Fallacies |
Alcibey Alvarado González |
| 2 |
[GO] |
2022―Mar―17 |
COVID-19 associated mucormycosis is not a direct consequence of SARS-CoV 2 induced immune dysfunction |
Luis Fonte, Carlos Manuel Fernandez Andreu, Maria Ginori, Yaxsier de Armas |
| 3 |
[GO] |
2021―May―12 |
COVID-19 re-infection presenting as acute ischemic stroke |
Marco Bongiovanni |
| 4 |
[GO] |
2021―Mar―24 |
PROGRAMMED CELL DEATH. REVIEW AND ITS IMPACT IN COVID-19 |
Alcibey Alvarado González |
| 5 |
[GO] |
2021―Mar―24 |
Benign clinical and epidemiological outcomes-associated factors of COVID-19 from a solved epidemic with a low case fatality rate |
Gang Hu, Jian Liu, Peng Yuan He, Li Juan Ouyang, Bao Jia Zou, Xiao Mou Peng |
| 6 |
[GO] |
2021―Mar―24 |
COVID-19 infection as a systemic disease |
Marco Bongiovanni, Alessandro Maria Marra |
| 7 |
[GO] |
2020―Dec―11 |
Advanced liver disease: It is not all about Covid-19 |
Del Pino Bellido Pilar, Guerra Veloz Maria Fernanda, Muñoz Garcia-Borruel Maria, Salamanca Rivera Elena, Carmona Soria Isabel |
| 8 |
[GO] |
2020―Dec―11 |
Covid-19 - Experience in Costa Rica |
Alcibey Alvarado |
| 9 |
[GO] |
2020―Dec―11 |
Amount of PPE against COVID-19 to Sub-Saharan Africa may determine the region’s uptake to patient care and clinical research |
Thomas Nyirenda, Min Jae Shin, Sue Min Shin, David S Chung |
| 10 |
[GO] |
2020―Dec―11 |
Clinical trials during COVID-19: Keeping clinical trial participants informed during this pandemic |
Wong LX, Chee B, Park JM |
| 11 |
[GO] |
2020―Jun―04 |
Coronavirus pandemic (COVID-19) - Clinical trials advice |
Daniele Novara |
